<DOC>
	<DOCNO>NCT01512654</DOCNO>
	<brief_summary>The primary purpose study see whether tool predict blood glucose suggest therapy advice help type 1 diabetic patient .</brief_summary>
	<brief_title>Personalized Glucose Predictive Therapy Advisory System - DIAdvisor 2</brief_title>
	<detailed_description>During study , would like assess efficacy keep blood glucose safe range ( 70-180 mg/dL ) second generation Glucose Predictive Therapy Advisory system diabetic patient treat basal-bolus insulin regimen use pump multiple daily injection . We want compare time spend safe range use predictor advisor output patient use . This randomize control crossover trial . Patient come two admission 3 day , one DIAdvisor system fully activate , one prediction advice feature disable .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Patient must age 18 ( inclusive ) 70 year old 2 . Patients diagnose type 1 type 2 diabetes accord WHO criteria least one year prior study entry 3 . Patient treat basalbolus insulin therapy use external pump multipledaily injection . The insulin regimen stable previous six month . NPH insulin use acceptable . 4 . Patient stable diabetes HbA1c ≥ 7.5 % &lt; 10.5 % ketoacidosis previous 6 month . 5 . Patient must Body Mass Index ( BMI ) low 35 Kg/m² 6 . Patient must willing undergo study procedures 7 . Patient must affiliate beneficiary social medical insurance 8 . Patient sign informed consent form prior study entry 1 . Patient pregnant , breast feeding period study 2 . Patient impair renal function creatinine blood concentration 150 μmol/L 3 . Patient liver disease ( ALAT , ASAT &gt; 2 x upper limit normal range ) 4 . Patient treat sulfamides , GLP1 analogues , DPPIV inhibitor glitazones 5 . Alcohol drug addiction , identify investigator screen visit 6 . Allergy sensor one component 7 . Manifest psychological disorder 8 . Patient health status compatible physical exercise 9 . Patient actively enrol another clinical trial part study within 30 day 10 . Persons deprive freedom , adult protect law vulnerable person</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>diabetes</keyword>
	<keyword>diadvisor</keyword>
	<keyword>type 1 diabetes</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>glucose prediction</keyword>
	<keyword>cgm prediction</keyword>
	<keyword>algorithm</keyword>
	<keyword>therapy advice</keyword>
</DOC>